MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA (MF-CTCL) EPIDEMIOLOGY AND TREATMENT PATHWAYS IN FRANCE AND SPAIN: NEW INSIGHTS FOR AN ACCURATE DESCRIPTION

被引:0
|
作者
D'Agostino, P. [1 ]
Lezzi, C. [1 ]
Kent, A. [2 ]
Sharp, E. [2 ]
Schmidt, F. [3 ]
Turini, M. M. [1 ]
机构
[1] Helsinn Healthcare SA, Lugano, Switzerland
[2] Polestar Insights, London, England
[3] Recordati Rare Dis, Puteaux La Defense, France
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRO64
引用
收藏
页码:S852 / S853
页数:2
相关论文
共 50 条
  • [41] HTLV-V - A NEW HUMAN RETROVIRUS ASSOCIATED WITH CUTANEOUS T-CELL LYMPHOMA (MYCOSIS-FUNGOIDES)
    FINE, RM
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1988, 27 (07) : 473 - 474
  • [42] A long path to diagnosis - from Ofuji papuloerythroderma to the atypical phenotype of a cutaneous T-cell lymphoma of the mycosis fungoides type
    Kussini, J.
    Arz, M.
    Hauser, C.
    Kroenig, L.
    Bender, A.
    Gschnell, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 36 - 37
  • [43] Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sezary syndrome): Use in a community setting
    Reddy, Sunil A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 99 - 107
  • [44] The efficacy and safety of extracorporeal photopheresis (ECP) for treatment of mycosis fungoides and/or se′zary syndrome in cutaneous T-cell lymphoma
    Stone, V.
    Mesa, O. A.
    Covassin, L.
    McCloskey, C.
    Chuang, L. H.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S81 - S81
  • [45] HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA PATIENTS: DETERMINATION OF UTILITY VALUES FROM A UK-BASED CLINICIAN QUESTIONNAIRE
    Scarisbrick, J.
    Schmidt, F.
    Turini, M. M.
    D'agostino, P.
    Thornton, S.
    Evans, J.
    Ader, J.
    van Hest, N.
    Brazier, J. E.
    VALUE IN HEALTH, 2020, 23 : S715 - S715
  • [46] Phase I Clinical Trial of O6-Benzylguanine and Topical Carmustine in the Treatment of Cutaneous T-Cell Lymphoma, Mycosis Fungoides Type
    Apisarnthanarax, Narin
    Wood, Gary S.
    Stevens, Seth R.
    Carlson, Sean
    Chan, Derek V.
    Liu, Lili
    Szabo, Sarolta K.
    Fu, Pingfu
    Gilliam, Anita C.
    Gerson, Stanton L.
    Remick, Scot C.
    Cooper, Kevin D.
    ARCHIVES OF DERMATOLOGY, 2012, 148 (05) : 613 - 620
  • [47] Contemporary treatment patterns and response in relapse/refractory cutaneous T-cell lymphoma (CTCL) in clinical practice in France, Germany Italy, Spain and the United Kingdom
    Illidge, T.
    Bagot, M.
    Waser, N.
    He, M.
    Li, T.
    Sambrook, R.
    Zomas, A.
    Trinchese, F.
    Gavini, F.
    Little, M.
    Ortiz, P.
    Pimpinelli, N.
    Dalal, M.
    Assaf, C.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S36 - S36
  • [48] Cutaneous T-cell lymphoma of mycosis fungoides type with CD30 positive transformation and sweet like neutrophilic dermatosis
    Andre, Florine
    Biogazi, Sofi A.
    Leuenberger, Mathieu
    Gaide, Olivier
    De Leval, Laurence
    Hohl, Daniel
    Prins, Christa
    Gillet, Michel
    Guenova, Emmanuella
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S58 - S59
  • [49] PATIENTS' EXPERIENCES WITH MYCOSIS FUNGOIDES/SEZARY SYNDROME - CUTANEOUS T-CELL LYMPHOMA (MF/SS-CTCL): EVIDENCE FROM QUALITATIVE RESEARCH OF A PATIENT REPORTED OUTCOME (PRO) MEASURE DEVELOPED ON AN ONLINE RESEARCH PLATFORM
    Towner, A.
    Raja, P.
    Braverman, J.
    Harrington, M.
    Simacek, K.
    Nagao, M.
    Sepassi, M.
    VALUE IN HEALTH, 2015, 18 (03) : A25 - A25
  • [50] Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience
    Geskin, Larisa J.
    Bagot, Martine
    Hodak, Emmilia
    Kim, Ellen J.
    DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1085 - 1106